BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9329369)

  • 1. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease.
    Martin A; Nakashima M; Zhou A; Aronson D; Werner AJ; Davies TF
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3361-6. PubMed ID: 9329369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain.
    Soliman M; Kaplan E; Yanagawa T; Hidaka Y; Fisfalen ME; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Mar; 80(3):905-14. PubMed ID: 7533773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in cellular and antibody responses against thyrotropin receptor in patients with Graves' disease detected using synthetic peptides.
    Fan JL; Desai RK; Seetharamaiah GS; Dallas JS; Wagle NM; Prabhakar BS
    J Autoimmun; 1993 Dec; 6(6):799-808. PubMed ID: 7512341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls.
    Kellermann SA; McCormick DJ; Freeman SL; Morris JC; Conti-Fine BM
    J Autoimmun; 1995 Oct; 8(5):685-98. PubMed ID: 8579724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor.
    Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ
    Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of an antihuman thyrotropin (TSH) receptor-specific CD4+ T cell line from a patient with Graves' disease: evidence for multiple T cell epitopes on the TSH receptor including the transmembrane domain.
    Akamizu T; Ueda Y; Hua L; Okuda J; Mori T
    Thyroid; 1995 Aug; 5(4):259-64. PubMed ID: 7488865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell recognition of residue 158-176 in thyrotropin receptor confers risk for development of thyroid autoimmunity in siblings in a family with Graves' disease.
    Soliman M; Kaplan E; Guimaraes V; Yanagawa T; DeGroot LJ
    Thyroid; 1996 Dec; 6(6):545-51. PubMed ID: 9001188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
    Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
    Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy.
    Wortsman J; McConnachie P; Tahara K; Kohn LD
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2302-8. PubMed ID: 9661599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
    Kim WB; Cho BY; Park HY; Lee HK; Kohn LD; Tahara K; Koh CS
    J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topics on immunogenic regions in TSH receptors for thyroid disease].
    Murakami M; Mori M
    Rinsho Byori; 1993 Feb; 41(2):128-35. PubMed ID: 7689665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the peptides that inhibit the stimulation of thyrotropin receptor by Graves' immunoglobulin G from peptide libraries.
    Park JY; Kim IJ; Lee MH; Seo JK; Suh PG; Cho BY; Ryu SH; Chae CB
    Endocrinology; 1997 Feb; 138(2):617-26. PubMed ID: 9002995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative responses of T-cells to thyroid antigens and synthetic thyroid peroxidase peptides in autoimmune thyroid disease.
    Fisfalen ME; Soliman M; Okamoto Y; Soltani K; DeGroot LJ
    J Clin Endocrinol Metab; 1995 May; 80(5):1597-604. PubMed ID: 7745006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.
    Li CW; Osman R; Menconi F; Concepcion E; Tomer Y
    J Autoimmun; 2020 Mar; 108():102402. PubMed ID: 31980336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin receptor T cell epitopes in autoimmune thyroid disease.
    Nagy EV; Morris JC; Burch HB; Bhatia S; Salata K; Burman KD
    Clin Immunol Immunopathol; 1995 May; 75(2):117-24. PubMed ID: 7535671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.
    Muehlberg T; Gilbert JA; Rao PV; McGregor AM; Banga JP
    Endocrinology; 2004 Apr; 145(4):1539-45. PubMed ID: 14764633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease.
    Côté-Bigras S; Dionne A; Asselin-Mullen P; Leblicq C; Rottembourg D
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):296-300. PubMed ID: 23734883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.